
Keywords: ERRγ inverse agonist; Nuclear receptor; ADMET; GSK5182; 4-OHT; 4-hydroxytamoxifen; ADMET; absorption, distribution, metabolism, excretion, and toxicity; CYP; cytochrome P450; DCM; dichloromethane; DES; diethylstilbestrol; ER; estrogen receptor; ERR; estr